Latest news

Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper.

GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymes

Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman

BioClick - an enzyme engineering game-changer

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer

Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

Chemical Engineering: Enzyme engineering breaks out of the cell

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

Fox Business: Interview with Chief Market Strategist, Lou Basenese